Journal of Hematology, ISSN 1927-1212 print, 1927-1220 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Hematol and Elmer Press Inc
Journal website http://www.thejh.org

Editorial

Volume 9, Number 1-2, April 2020, pages 1-4

Abnormal Hemostatic Parameters and Risk of Thromboembolism Among Patients With COVID-19 Infection

Figures

Figure 1.
Figure 1. Prophylaxis of venous thromboembolism therapy scheme for COVID-19 diagnosed outpatients with mild disease.
Figure 2.
Figure 2. Prophylaxis of venous thromboembolism therapy scheme for COVID-19 hospitalized patients.
Figure 3.
Figure 3. Prophylaxis of venous thromboembolism therapy scheme for COVID-19 ICU patients. ICU: intensive care unit.

Table

Table 1. Coagulation Parameters in COVID-19 DIC, Acute DIC and Chronic DIC
 
ParametersCOVID-19 DICAcute (decompensated) DICChronic (compensated) DIC
DIC: disseminated intravascular coagulation; PT: prothrombin time; aPTT: activated partial thromboplastin time.
Platelet countNormal or reducedReducedVariable
PTNormal or prolongedProlongedNormal
aPTTNormal or prolongedProlongedNormal
Thrombin timeNormal or prolongedProlongedNormal to slightly prolonged
Plasma fibrinogenElevatedReducedNormal to elevated
Plasma factor VIIIElevatedReducedNormal
Fibrin degradation productsElevatedElevatedElevated
D-dimerElevatedElevatedElevated